Trials / Conditions / Extraskeletal Myxoid Chondrosarcoma
Extraskeletal Myxoid Chondrosarcoma
5 registered clinical trials studyying Extraskeletal Myxoid Chondrosarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T NCT06526897 | ECOG-ACRIN Cancer Research Group | N/A |
| Unknown | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) NCT05266196 | Salarius Pharmaceuticals, LLC | Phase 1 / Phase 2 |
| Unknown | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom NCT03600649 | Salarius Pharmaceuticals, LLC | Phase 1 |
| Active Not Recruiting | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma NCT02066285 | Grupo Espanol de Investigacion en Sarcomas | Phase 2 |